GlassScriptPhysician profile
James S Robertson
NPI 1669469961
$10,767.54
in general payments reported to CMS, 2019-2025
44 companies · $22.90 in 2025
The $22.90 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $949 · 2020: $2,056 · 2021: $1,331 · 2022: $872 · 2023: $993 · 2024: $4,543 · 2025: $22.90.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,668 · Education: $1,500 · Food and Beverage: $1,391.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,668.47 |
| Education | $1,500.00 |
| Food and Beverage | $1,390.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,254.87 | 2024 | |
| Coloplast Corp | $1,522.82 | 2019-2024 | Altis |
| Abbvie INC. | $926.68 | 2019-2024 | Orilissa, Lo Loestrin Fe, Liletta |
| Takeda Pharmaceuticals U.S.A., INC. | $474.43 | 2020-2024 | Trintellix |
| Caldera Medical, INC | $400.39 | 2019-2021 | |
| Allergan, INC. | $278.98 | 2019-2022 | |
| Currax Pharmaceuticals LLC | $221.43 | 2019-2024 | Contrave, Onzetra Xsail |
| Sanara Medtech INC. | $218.70 | 2021-2022 | |
| Ethicon US, LLC | $216.98 | 2020-2022 | |
| Lupin INC. | $206.08 | 2019-2021 | |
| Novo Nordisk INC | $194.94 | 2019-2024 | Wegovy |
| Aspira Women'S Health INC | $172.37 | 2021-2022 | |
| Pfizer INC. | $171.58 | 2019-2024 | |
| Femselect INC. | $161.39 | 2023 | Enplace |
| Sumitomo Pharma America, INC. | $140.65 | 2023-2025 | Myfembree, Gemtesa |
Show all 44 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Robertson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.